Kaiser Permanente
Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
A new study from Kaiser Permanente Division of Research investigators suggests one factor in late-life cognitive decline may be how intellectually challenging a person’s job is.
People attending schools in states with higher state-level educational quality are less likely to develop dementia in late life, according to a new Kaiser Permanente analysis published in JAMA Neurology.
A Kaiser Permanente analysis of prenatal exposure to the persistent environmental chemicals known as PFAS found suggestive evidence of an association with autism-related traits in children for just 1 of 8 PFAS chemicals studied.
A Kaiser Permanente genetic analysis found 82 locations on the human genome associated with migraine, 48 of them newly identified, including 3 specific to women, who experience migraine much more frequently than men.
Kaiser Permanente study finds declines in heart attack hospitalizations and emergency care for possible strokes reported during onset of the COVID-19 pandemic not seen in subsequent surges.
Even if emergency personnel were able to use the best stroke assessment tool available, most patients taken directly by ambulance to a comprehensive stroke center could have been treated at a primary stroke center instead, a new Kaiser Permanente study suggests.
The new Kaiser Permanente study findings support previous research that suggests fear of contracting the novel coronavirus in a medical setting may have kept people from receiving critically needed medical care.
Young people with autism use more health care services and need assistance transitioning from pediatric to adult medical care, according to 2 new studies by researchers with the Kaiser Permanente Division of Research.
Analysis finds that neurological side effects from the anti-seizure medication phenytoin are more common in patients with certain genetic variants that were also associated with lower adherence to treatment, suggesting they may play a role in patients finding the right medication.
Women who start their period later, go through menopause earlier or have a hysterectomy may have a greater risk of developing dementia, according to a new study led by Kaiser Permanente researchers and published in the journal, Neurology.
